Search - tctmd.com

Displaying 521 - 540 of 557

Sort: Relevancy | Date

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

October 06, 2015

News Industry News

Occlutech obtains European CE Approval for its novel mVSD Device

September 30, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

Presentation Fellows 2015

Update on Mitral Valve Disease and Transcatheter Therapies

Presenter: Mark Reisman, Nirat Beohar, Michael J. Rinaldi

May 17, 2015

Presentation Fellows 2015

Practical Aspects of TAVR: Procedural Planning, Imaging, and How to Do These Cases Safely

Presenter: Mark Reisman, Nirat Beohar, Duane S. Pinto

May 17, 2015

Presentation Fellows 2015

Indications and Treatment Options for Aortic Stenosis: Past, Present, and Future

Presenter: Mark Reisman, Nirat Beohar, Tamim Nazif

May 17, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

Presentation TCT 2014

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Albert Hsiao

September 15, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

Presentation TCT 2013

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 29, 2013

Presentation Transradial 2013

Transradial Skills in Structural Heart Disease?

Presenter: Josep Rod?s-Cabau

June 28, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

Advertisement

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

Boston Scientific Announces Scheduled Presentations At TCT 2015

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

Occlutech obtains European CE Approval for its novel mVSD Device

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

Statement on LAA Closure Highlights Key Issues for Growing Field

CTOs Relatively Frequent in Patients Without Previously Known CAD

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Update on Mitral Valve Disease and Transcatheter Therapies

Practical Aspects of TAVR: Procedural Planning, Imaging, and How to Do These Cases Safely

Indications and Treatment Options for Aortic Stenosis: Past, Present, and Future

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Medtronic CoreValve® System Obtains Early FDA Approval

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Transradial Skills in Structural Heart Disease?

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content